Journal of Cancer Research and Therapeutics Close
 

Figure 2: The graphical presentation of the viability of cancer cell lines when TP53 expressing vector used in combination with nitroreductase mutants, T41L/F70A or F124N. The percent of cell vitality is shown in untreated, green fluorescent protein-, TP53-, and NTR-treated cell lines. As it is shown, results of combination use of TP53 and T41L/F70A or F124N are statistically significant in all cell lines compared to each case alone (P < 0.05). Y axis shows cell viability and X axis shows the virus type. **Statistical significant

Figure 2: The graphical presentation of the viability of cancer cell lines when TP53 expressing vector used in combination with nitroreductase mutants, T41L/F70A or F124N. The percent of cell vitality is shown in untreated, green fluorescent protein-, TP53-, and NTR-treated cell lines. As it is shown, results of combination use of TP53 and T41L/F70A or F124N are statistically significant in all cell lines compared to each case alone (<i>P</i> < 0.05). Y axis shows cell viability and X axis shows the virus type. **Statistical significant